Decoding astrocytic tryptophan metabolism in the pathogenesis of epilepsy: evidence from artificial intelligence-driven multi-omics and clinical validation.
Overview
- Department of Neurology, Children’s Hospital of Shanxi, Shanxi Maternal and Child Health Hospital, The Affiliated Children’s Hospital of Shanxi Medical University, Taiyuan, Shanxi, China
- Department of Neurology, First Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi, China
Abstract
Background: Epilepsy (EP) is a prevalent neurological disorder with complex etiology, often involving metabolic dysregulation. Emerging evidence highlights the role of tryptophan metabolism (TM) and astrocyte dysfunction in EP pathogenesis. This study aimed to decode the TM and astrocyte (TA)-related molecular signature and identify a central therapeutic target for EP.
Methods: By integrating seven hippocampal bulk profiles (GSE28674, GSE256068, GSE57585, GSE163296, GSE63808, GSE90886, and GSE134697) from patients with EP using integrative bioinformatics pipelines, including limma, xCell, WGCNA, machine learning, and consensus clustering, we identified a TA-associated diagnostic signature and a molecular stratification model for EP. Next, the TA-associated hub gene was identified by SHAP analysis, and its molecular patterns in astrocytes were characterized using single-cell hippocampal data from patients with EP (GSE190452). In addition, the active-learning framework DrugReflector and molecular docking were used to identify a potential therapeutic agent targeting the TA-associated hub gene in the integrated GSE63808 and GSE90886 dataset. Finally, hippocampal tissue from patients with EP was used to examine expression of the TA-associated hub gene.
Results: Four TA-associated shared DEGs were identified: CAT, TXNDC2, RBM27, and GPT. These four DEGs showed predictive value for EP. RBM27 was identified as the central pathogenic factor; it was upregulated and predominantly expressed in astrocytes. Drug prediction identified BRD-K04111260 as a promising compound targeting RBM27 for the treatment of EP.
Conclusion: This study establishes a novel TA-associated molecular axis in EP pathogenesis, identifying RBM27 as a critical hub gene with strong diagnostic potential and therapeutic promise.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE28674, at NCBI GEO; found in the text, “Bulk profile identification”
Data availability statement
The datasets presented in this study can be found in online repositories. The names of the repository/
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, pages, dates, 2 authors, 5 keywords, 44 references.
Cite
This paper
Wang, W., & Sun, M. (2026). Decoding astrocytic tryptophan metabolism in the pathogenesis of epilepsy: evidence from artificial intelligence-driven multi-omics and clinical validation. Frontiers in neuroscience, 20, 1913179. https://
BibTeX
@article{wang2026decodin
author = {Wang, Wenhui and Sun, Meizhen},
title = {{Decoding astrocytic tryptophan metabolism in the pathogenesis of epilepsy: evidence from artificial intelligence-driven multi-omics and clinical validation}},
journal = {Frontiers in neuroscience},
year = {2026},
month = aug,
volume = {20},
pages = {1913179},
publisher = {Frontiers Media SA},
issn = {1662-4548},
doi = {10.3389/
url = {https://
pmid = {42677124},
pmcid = {PMC13528210}
}
RIS
TY - JOUR
AU - Wang, Wenhui
AU - Sun, Meizhen
TI - Decoding astrocytic tryptophan metabolism in the pathogenesis of epilepsy: evidence from artificial intelligence-driven multi-omics and clinical validation
T2 - Frontiers in neuroscience
J2 - Front Neurosci
PY - 2026
DA - 2026/
VL - 20
SP - 1913179
SN - 1662-4548
PB - Frontiers Media SA
DO - 10.3389/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.3389/
"type": "article-journal",
"title": "Decoding astrocytic tryptophan metabolism in the pathogenesis of epilepsy: evidence from artificial intelligence-driven multi-omics and clinical validation",
"container-title": "Frontiers in neuroscience",
"author": [
{
"family": "Wang",
"given": "Wenhui"
},
{
"family": "Sun",
"given": "Meizhen"
}
],
"container-title-short":
"volume": "20",
"page": "1913179",
"DOI": "10.3389/
"PMID": "42677124",
"PMCID": "PMC13528210",
"ISSN": "1662-4548",
"publisher": "Frontiers Media SA",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
17
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.3389/fnins.2026.1848128
- Assessment of tenecteplase target-associated pathogenic mechanisms underlying depression in acute ischemic stroke patients: insights from artificial intelligence-driven multi-omics analysis and &
lt;i& gt;in vitro& lt;/ i& gt; validation. Journal: Frontiers in neuroscienceIn common: genetics / omics, 8 references - [2] doi:10.3389/fnins.2026.1929767
- Tracing fucosylation and astrocyte-associated pathogenic pattern in major depressive disorder: evidence from machine learning-based multi-omics and clinical validation.Journal: Frontiers in neuroscienceIn common: genetics / omics, cellular / molecular, 7 references
- [3] doi:10.1515/med-2023-0675
- miR-30b-5p targeting GRIN2A inhibits hippocampal damage in epilepsy.Journal: Open medicine (Warsaw, Poland)In common: NCBI GEO GSE28674, epilepsy, cellular / molecular, 2 references
- [4] doi:10.3389/fnagi.2026.1727472
- Artificial intelligence and multi-omics nominate TAZ as an insomnia-related diagnostic and druggable target for Parkinson's disease patients.Journal: Frontiers in aging neuroscienceIn common: genetics / omics, 8 references
- [5] doi:10.3389/fnins.2026.1950353
- A neuron-distributed DEK integrates ac4C modification and neuroinflammation in pathogenesis of Parkinson disease: evidence from Mendelian randomization, multi-omics and &
lt;i& gt;in vitro& lt;/ i& gt; validation. Journal: Frontiers in neuroscienceIn common: genetics / omics, cellular / molecular, 5 references - [6] doi:10.25259/cytojournal_47_2025
- Study on the correlation between Interleukin 4 and febrile seizures.Journal: CytoJournalIn common: NCBI GEO GSE28674, epilepsy, cellular / molecular
- [7] doi:10.1038/s41598-023-37535-w
- Transcriptomic analysis reveals distinct adaptive molecular mechanism in the hippocampal CA3 from rats susceptible or not-susceptible to hyperthermia-induced seizures.Journal: Scientific reportsIn common: epilepsy, genetics / omics, cellular / molecular, 3 references
- [8] doi:
- Identification of microglia-associated hub genes and a CX3CR1/
P2RY12 two-gene diagnostic model for cross-subtype epilepsy-associated cortical malformations: integrated transcriptomic analysis with external validation Journal: Frontiers in neuroscienceIn common: epilepsy, genetics / omics, 5 references - [9] doi:10.3390/cimb47090727
- Transcriptomic Analysis Reveals the Molecular Relationship Between Common Respiratory Infections and Parkinson's Disease.Journal: Current issues in molecular biologyIn common: genetics / omics, cellular / molecular, 5 references
- [10] doi:10.1186/s12920-023-01458-2
- Identification of immune cells infiltrating in hippocampus and key genes associated with Alzheimer's disease.Journal: BMC medical genomicsIn common: genetics / omics, cellular / molecular, 5 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
